Stephen I. Bandak

416 total citations
9 papers, 245 citations indexed

About

Stephen I. Bandak is a scholar working on Epidemiology, Neurology and Pharmacology. According to data from OpenAlex, Stephen I. Bandak has authored 9 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Neurology and 2 papers in Pharmacology. Recurrent topics in Stephen I. Bandak's work include Pneumonia and Respiratory Infections (4 papers), Neurological disorders and treatments (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Stephen I. Bandak is often cited by papers focused on Pneumonia and Respiratory Infections (4 papers), Neurological disorders and treatments (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Stephen I. Bandak collaborates with scholars based in United States, Canada and Romania. Stephen I. Bandak's co-authors include Debra A. Gusnard, Kevin J. Black, Meghan C. Campbell, Jonathan M. Koller, Christopher Kenney, Emmanuelle Pourcher, Karl Kieburtz, C. Warren Olanow, Mark Lew and Any Docu Axelerad and has published in prestigious journals such as Journal of Neuroscience, The Lancet Neurology and Movement Disorders.

In The Last Decade

Stephen I. Bandak

9 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen I. Bandak United States	6	96	87	77	59	34	9	245
Max Borsche Germany	9	174 1.8×	9 0.1×	82 1.1×	132 2.2×	57 1.7×	27	361
Ana M. García-Cabrero Spain	8	89 0.9×	9 0.1×	91 1.2×	97 1.6×	36 1.1×	8	407
Célia Nogueira Portugal	8	10 0.1×	106 1.2×	93 1.2×	83 1.4×	17 0.5×	15	314
Martina Giuntini Italy	9	135 1.4×	12 0.1×	24 0.3×	26 0.4×	19 0.6×	12	229
Elizabeth M. Podhaizer United States	9	13 0.1×	14 0.2×	89 1.2×	100 1.7×	40 1.2×	9	391
Mohan Kumar Muthu Karuppan United States	8	60 0.6×	10 0.1×	25 0.3×	60 1.0×	66 1.9×	11	289
Pedro Beleza Portugal	8	50 0.5×	4 0.0×	104 1.4×	36 0.6×	17 0.5×	16	291
Usha Dave India	11	16 0.2×	5 0.1×	22 0.3×	63 1.1×	28 0.8×	22	287
Hany El‐Naggar Ireland	11	30 0.3×	31 0.4×	73 0.9×	224 3.8×	11 0.3×	21	463
Jessica L. Klein United States	9	35 0.4×	6 0.1×	58 0.8×	197 3.3×	20 0.6×	14	321

Countries citing papers authored by Stephen I. Bandak

Since Specialization

Citations

This map shows the geographic impact of Stephen I. Bandak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen I. Bandak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen I. Bandak more than expected).

Fields of papers citing papers by Stephen I. Bandak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen I. Bandak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen I. Bandak. The network helps show where Stephen I. Bandak may publish in the future.

Co-authorship network of co-authors of Stephen I. Bandak

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen I. Bandak. A scholar is included among the top collaborators of Stephen I. Bandak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen I. Bandak. Stephen I. Bandak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Olanow, C. Warren, Christopher Kenney, Stephen I. Bandak, & Karl Kieburtz. (2018). Adverse event reporting in clinical trials in Parkinson's Disease: Time for change. Movement Disorders. 33(11). 1685–1687. 2 indexed citations

Garza, Richard De La, Marcy J. Bubar, F. Gerard Moeller, et al.. (2015). Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 59. 40–48. 13 indexed citations

Hauser, Robert A., C. Warren Olanow, Karl Kieburtz, et al.. (2014). Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial. The Lancet Neurology. 13(8). 767–776. 103 indexed citations

Moeller, F. Gerard, Joel L. Steinberg, Scott D. Lane, et al.. (2012). Increased Orbitofrontal Brain Activation after Administration of a Selective Adenosine A2A Antagonist in Cocaine Dependent Subjects. Frontiers in Psychiatry. 3. 44–44. 18 indexed citations

Black, Kevin J., Jonathan M. Koller, Meghan C. Campbell, Debra A. Gusnard, & Stephen I. Bandak. (2010). Quantification of Indirect Pathway Inhibition by the Adenosine A_2aAntagonist SYN115 in Parkinson Disease. Journal of Neuroscience. 30(48). 16284–16292. 69 indexed citations

Bandak, Stephen I., et al.. (2001). Antimicrobial susceptibilities of clinical isolates of Haemophilus influenzae and Moraxella catarrhalis collected during 1999–2000 from 13 countries. Clinical Microbiology and Infection. 7(12). 671–677. 18 indexed citations

Bandak, Stephen I., et al.. (2001). Antibiotic Susceptibilities Among Recent Clinical Isolates of Haemophilus influenzae and Moraxella catarrhalis from Fifteen Countries. European Journal of Clinical Microbiology & Infectious Diseases. 20(1). 55–60. 18 indexed citations

Bandak, Stephen I., et al.. (2000). Assessment of the Susceptibility ofStreptococcus pneumoniaeto Cefaclor and Loracarbef in 13 Countries. Journal of Chemotherapy. 12(4). 299–305. 3 indexed citations

Bandak, Stephen I., et al.. (1999). Cefaclor advanced formulation 750 mg twice daily versus clarithromycin 500 mg twice daily in the treatment of acute maxillary sinusitis. Current Therapeutic Research. 60(4). 185–194. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact